-
2021-12-23
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
Aerogen Pharma announces an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening condition of preterm infants associated with long-term lung health issues in survivors.
-
2021-06-10
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China
Verona Pharma plc (Nasdaq: VRNA) and Nuance Pharma Limited today announce that the companies have entered into an agreement granting Nuance Pharma, a Shanghai
- 1
Contact PR
